General Cardiology

Featured Content

AHA Guidance for the Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy

Scientific statement by the AHA provides up-to-date information and recommendations for the diagnosis and management of transthyretin amyloid cardiomyopathy.

Latest News

Rilonacept Reduces Risk for Recurrent Pericarditis Events in Phase 3 Trial

Kiniksa Pharmaceuticals announced positive data from the phase 3 RHAPSODY trial evaluating rilonacept for the treatment of recurrent pericarditis.

Inhibition of Sclerostin May Increase Cardiovascular Risk

Inhibition of sclerostin with romosozumab may increase cardiovascular risk, according to research published in the June 24 issue of Science Translational Medicine.

Subclinical Hypothyroidism in NAFLD Is Associated With All-Cause and Cardiovascular Mortality

Low thyroid function is associated with nonalcoholic fatty liver disease and predicted all-cause and cardiovascular mortality in this population.

AHA Statement on Managing Pregnant Women With CVD

The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.

Cardioprotective Therapy Use Lower With Cancer History

Cardioprotective therapies, especially statins and antiplatelets, are underutilized in patients with a history of cancer (CaHx).

CMR Criteria to Distinguish Patients With NCCM With Likely Pathogenic Variant

CMR criteria along with family history can determine those patients in whom a (likely) pathogenic variant for noncompaction cardiomyopathy can be identified.

Improved Algorithms Needed to Identify Intravenous Drug Use-Associated Endocarditis

A team of investigators reviewed data from institutions within the VA healthcare system to assess the ability of 2 algorithms to identify patients with intravenous drug use-associated infective endocarditis.

Midlife Blood Pressure During Exercise Predicts Later Heart Disease

Higher blood pressure (BP) during exercise and impaired BP recovery after exercise in midlife may be markers of subclinical and clinical cardiovascular disease and mortality in later life.

CVD, Non-CVD Mortality Increased With Azithromycin Use

Outpatient azithromycin use is associated with an increased risk for cardiovascular and noncardiovascular mortality.

Baseline DBP Does Not Modify CVD Benefit of Intensive SBP Lowering in Standard Glycemic Therapy for T2D

Baseline diastolic blood pressure does not affect the cardiovascular benefits of intensive lowering of systolic blood pressure in patients with type 2 diabetes.